Literature DB >> 12933526

Assessing the effect of an influenza vaccine in an encouragement design.

K Hirano1, G W Imbens, D B Rubin, X H Zhou.   

Abstract

Many randomized experiments suffer from noncompliance. Some of these experiments, so-called encouragement designs, can be expected to have especially large amounts of noncompliance, because encouragement to take the treatment rather than the treatment itself is randomly assigned to individuals. We present an extended framework for the analysis of data from such experiments with a binary treatment, binary encouragement, and background covariates. There are two key features of this framework: we use an instrumental variables approach to link intention-to-treat effects to treatment effects and we adopt a Bayesian approach for inference and sensitivity analysis. This framework is illustrated in a medical example concerning the effects of inoculation for influenza. In this example, the analyses suggest that positive estimates of the intention-to-treat effect need not be due to the treatment itself, but rather to the encouragement to take the treatment: the intention-to-treat effect for the subpopulation who would be inoculated whether or not encouraged is estimated to be approximately as large as the intention-to-treat effect for the subpopulation whose inoculation status would agree with their (randomized) encouragement status whether or not encouraged. Thus, our methods suggest that global intention-to-treat estimates, although often regarded as conservative, can be too coarse and even misleading when taken as summarizing the evidence in the data for the effects of treatments.

Year:  2000        PMID: 12933526     DOI: 10.1093/biostatistics/1.1.69

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  44 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Bias Mechanisms in Intention-to-Treat Analysis With Data Subject to Treatment Noncompliance and Missing Outcomes.

Authors:  Booil Jo
Journal:  J Educ Behav Stat       Date:  2007-01-01

3.  THE POTENTIAL FOR BIAS IN PRINCIPAL CAUSAL EFFECT ESTIMATION WHEN TREATMENT RECEIVED DEPENDS ON A KEY COVARIATE.

Authors:  Corwin M Zigler; Thomas R Belin
Journal:  Ann Appl Stat       Date:  2011       Impact factor: 2.083

4.  Semiparametric transformation models for causal inference in time to event studies with all-or-nothing compliance.

Authors:  Wen Yu; Kani Chen; Michael E Sobel; Zhiliang Ying
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2015-03-01       Impact factor: 4.488

5.  Doubly robust estimation of the local average treatment effect curve.

Authors:  Elizabeth L Ogburn; Andrea Rotnitzky; James M Robins
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2015-03       Impact factor: 4.488

6.  Cluster randomized trials with treatment noncompliance.

Authors:  Booil Jo; Tihomir Asparouhov; Bengt O Muthén; Nicholas S Ialongo; C Hendricks Brown
Journal:  Psychol Methods       Date:  2008-03

7.  Causal Mediation Analyses for Randomized Trials.

Authors:  Kevin G Lynch; Mark Cary; Robert Gallop; Thomas R Ten Have
Journal:  Health Serv Outcomes Res Methodol       Date:  2008

8.  Causal inference in randomized experiments with mediational processes.

Authors:  Booil Jo
Journal:  Psychol Methods       Date:  2008-12

9.  Estimating the health benefit of reducing indoor air pollution in a randomized environmental intervention.

Authors:  Roger D Peng; Arlene M Butz; Amber J Hackstadt; D'Ann L Williams; Gregory B Diette; Patrick N Breysse; Elizabeth C Matsui
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2014-07-15       Impact factor: 2.483

Review 10.  Adaptive designs for randomized trials in public health.

Authors:  C Hendricks Brown; Thomas R Ten Have; Booil Jo; Getachew Dagne; Peter A Wyman; Bengt Muthén; Robert D Gibbons
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.